Alnylam Pharmaceuticals
ALNY
#813
Rank
$30.04 B
Marketcap
$224.53
Share price
0.05%
Change (1 day)
-50.18%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company